eflornithine
Showing 1 - 17 of 17
Gastric Cancer, Gastric Intestinal Metaplasia Trial in Copán, San Juan (Eflornithine, Eflornithine )
Active, not recruiting
- Gastric Cancer
- Gastric Intestinal Metaplasia
- Eflornithine
- Eflornithine placebo
-
Copán, Honduras
- +1 more
Aug 17, 2022
Neuroblastoma Trial in Canada, United States (Eflornithine)
Recruiting
- Neuroblastoma
- Eflornithine
-
Little Rock, Arkansas
- +22 more
Jan 23, 2023
Familial Adenomatous Polyposis Trial in Worldwide (Eflornithine, Eflornithine Placebo, Sulindac 150 MG)
Completed
- Familial Adenomatous Polyposis
- Eflornithine
- +3 more
-
La Jolla, California
- +16 more
May 12, 2021
Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)
Not yet recruiting
- Diffuse Glioma
- Malignant Glioma
- Biospecimen Collection
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 6, 2023
Colorectal Cancer, Familial Adenomatous Polyposis Trial in Houston (Celecoxib, Placebo, eflornithine)
Completed
- Colorectal Cancer
- Familial Adenomatous Polyposis
- Celecoxib
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 8, 2020
Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)
Active, not recruiting
- Anaplastic Astrocytoma
- Recurrent Anaplastic Astrocytoma
- Eflornithine
- Lomustine
-
Birmingham, Alabama
- +78 more
Jan 19, 2022
Non-melanomatous Skin Cancer Trial (eflornithine)
Completed
- Non-melanomatous Skin Cancer
- eflornithine
- (no location specified)
Dec 12, 2019
Cervical Cancer, Precancerous Condition Trial in Houston (Eflornithine, Placebo)
Completed
- Cervical Cancer
- Precancerous Condition
- Eflornithine
- Placebo
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Oct 24, 2018
Non-melanomatous Skin Cancer, Precancerous/Nonmalignant Condition Trial in Tucson (eflornithine, triamcinolone)
Completed
- Non-melanomatous Skin Cancer
- Precancerous/Nonmalignant Condition
- eflornithine
- triamcinolone
-
Tucson, ArizonaArizona Cancer Center
Sep 7, 2018
Prostate Cancer Trial in Orange (eflornithine, Placebo)
Completed
- Prostate Cancer
- eflornithine
- Placebo
-
Orange, CaliforniaChao Family Comprehensive Cancer Center at University of Califor
Apr 11, 2018
Human African Trypanosomiasis (HAT), Sleeping Sickness Trial in Central African Republic, Congo, Congo, The Democratic Republic
Completed
- Human African Trypanosomiasis (HAT)
- Sleeping Sickness
- Fexinidazole
- +2 more
-
Batangafo, Central African Republic
- +9 more
Feb 17, 2018
Trypanosomiasis, African Trial in Congo, Congo, The Democratic Republic of the (Eflornithine, Nifurtimox)
Completed
- Trypanosomiasis, African
- Eflornithine
- Nifurtimox
-
Isangi, Congo, The Democratic Republic of the
- +3 more
Sep 28, 2016
Precancerous Condition Trial in Orange (, eflornithine, sulindac)
Completed
- Precancerous Condition
- placebo
- +3 more
-
Orange, CaliforniaUniversity of California Medical Center At Irvine-Orange Campus
Jan 12, 2015
Prostate Cancer Trial in Birmingham (bicalutamide, eflornithine, oral eflornithine )
Completed
- Prostate Cancer
- bicalutamide
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Comprehensive Cancer Center
Nov 17, 2013
Bladder Cancer Trial in United States (eflornithine)
Completed
- Bladder Cancer
- eflornithine
-
Birmingham, Alabama
- +60 more
Dec 17, 2013
Esophageal Cancer Trial in United States (eflornithine)
Completed
- Esophageal Cancer
- eflornithine
-
New Orleans, Louisiana
- +4 more
Dec 18, 2012